Guided Therapeutics, Inc. 

(Public, OTC:GTHP)   Watch this stock   
Find more results for GTHP

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -358.75% -365.22%
Operating margin -174.18% -232.88%
EBITD margin - -232.35%
Return on average assets -736.39% -519.44%
Return on average equity - -
Employees 17 -

Address

4955 Avalon Ridge Parkway Suite 300
Nocross, GA 30071
United States - Map
+1-770-2428723 (Phone)
+1-770-2428639 (Fax)

Website links

Guided Therapeutics, Inc. discussions

  View all discussions »

Description

Guided Therapeutics, Inc. is a medical technology company developing and providing products for the non-invasive cervical cancer detection and diabetes markets. The Company uses its technologies to develop non-invasive diagnostic devices, such as its cervical cancer detection product. The Company's products in development cancer detection are based upon its biophotonic technologies. The Company’s technology, including products in research and development, includes biophotonics technology for the non-invasive detection of cancers, including cervical cancer, and methods of measuring biologically important molecules in blood and interstitial fluid, such as glucose, alcohol and cortisol using specialized sensors and collection devices.

Officers and directors

William E. Zachary Jr.
Acting Chairman of the Board
Age: 66
Mark L. Faupel Ph.D.
President, Chief Executive Officer, Acting Chief Financial Officer, Director
Age: 54
Richard L. Fowler
Senior Vice President - Engineering, Secretary
Age: 52
Shabbir Bambot Ph.D.
Vice President - Research & Development
Age: 43
John E. Imhoff M.D.
Director
Age: 57
Michael C. James
Director
Age: 50
Ronald W. Hart Ph.D.
Director
Age: 66
Ronald W. Allen
Director
Age: 67